Advertisement

ACTH-Secreting Adenomas

  • Mark E. Molitch

Abstract

Cushing’s syndrome refers to the clinical and biochemical manifestations due to hypercortisolism of any cause. Hypercortisolism may be due to (1) pharmacological administration of glucocorticoids or adrenocorticotropic hormone (ACTH); (2) excessive, autonomous secretion by an adrenal adenoma or carcinoma; (3) excessive adrenal secretion secondary to increased pituitary secretion of ACTH; or (4) excessive adrenal secretion secondary to the ectopic secretion of ACTH or possibly corticotropin-releasing factor (CRF) by a neoplasm. Cushing’s disease specifically refers to the entity of excess ACTH secretion by the pituitary with resultant bilateral adrenal hyperplasia and hypercortisolism. Because therapeutic modalities for these entities are different, careful endocrinological and radiological evaluations are needed to differentiate between them.

Keywords

Cortisol Level Pituitary Adenoma Pituitary Tumor Transsphenoidal Surgery Adrenal Adenoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    D.T. Krieger and E.A. Zimmerman, The nature of CRF and its relationship to vasopressin, in: Clinical Neuroendocrinology (L. Martini and G.M. Besser, eds.), pp. 363–391, Academic Press, New York, 1977.Google Scholar
  2. 2.
    J.B. Martin, S. Reichlin, and G.M. Brown, Clinical Neuroendocrinology, F.A. Davis, Philadelphia, 1977.Google Scholar
  3. 3.
    M. Motta, F. Piva, and L. Martini, The role of “short” feedback mechanisms in the regulation of adrenocorticotropin secretion, Prog. Brain Res. 32:25, 1970.PubMedCrossRefGoogle Scholar
  4. 4.
    B. Török, Structure of the vascular connections of the hypothalamo-hypophysial region, Acta Anat. 59:84, 1964.CrossRefGoogle Scholar
  5. 5.
    R.M. Bergland, S.L. Davis, and R.B. Page, Pituitary secretes to brain: Experiments in sheep, Lancet 2:276, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    C. Oliver, R.S. Mical, and J.C. Porter, Hypothalamic-pituitary vasculature: Evidence for retrograde blood flow in the pituitary stalk, Endocrinology 101:598, 1977.PubMedCrossRefGoogle Scholar
  7. 7.
    D.T. Krieger, A. Liotta, and M.J. Brownstein, Presence of corticotropin in brain of normal and hypophysectomized rats, Proc. Natl. Acad. Sci. U.SA. 74:648, 1977.CrossRefGoogle Scholar
  8. 8.
    R. Moldow and R.S. Yalow, Extrahypophysial distribution of corticotropin as a function of brain size, Proc. Natl. Acad. Sci. U.SA. 75:994, 1978.CrossRefGoogle Scholar
  9. 9.
    S.J. Watson, C.W. Richard III, and J.D. Barchas, Adrenocorticotropin in rat brain: Immunocy-tochemical localization in cells and axons, Science 200:1180, 1978.PubMedCrossRefGoogle Scholar
  10. 10.
    E.D. Weitzman, D. Fukushima, C. Nogeire, H. Roffwarg, T.F. Gallagher, and L. Hellman, Twenty-four hour pattern of the episodic secretion of Cortisol in normal subjects, J. Clin. Endocrinol. Metab. 33:14, 1971.PubMedCrossRefGoogle Scholar
  11. 11.
    D.T. Krieger, Serotonin regulation of ACTH secretion, Ann. N.Y. Acad. Sci. 297:527, 1977.PubMedCrossRefGoogle Scholar
  12. 12.
    J. Vernikos-Danellis, K.J. Kellar, D. Kent, C. Gonzales, P.A. Berger, and D. Barchas, Serotonin involvement in pituitary-adrenal function, Ann. NY. Acad. Sci. 297:518, 1977.PubMedCrossRefGoogle Scholar
  13. 13.
    D.T. Krieger, L. Amorosa, and F. Linick, Cyproheptadine-induced remission of Cushing’s disease, N. Engl. J. Med. 293:893, 1975.PubMedCrossRefGoogle Scholar
  14. 14.
    S.M. McCann, S.R. Ojeda, P.G. Harms, J.E. Wheaton, D.K. Sundberg, and C.P. Fawcett, Control of adenohypophyseal hormone secretion by prostaglandins, in: Subcellular Mechanisms in Reproductive Neuroendocrinology (F. Naftolin, K.J. Ryan, and J. Davies, eds.), pp. 407–422, Elsevier, Amsterdam, 1976.Google Scholar
  15. 15.
    R. Guillemin, Endocrinology of the neuron, in: The Hypothalamus (S. Reichlin, R.J. Baldes-sarini, and J.B. Martin, eds.), pp. 155–194, Raven Press, New York, 1978.Google Scholar
  16. 16.
    G.R. Uhl, S.R. Childers, and S.H. Snyder, Opioid peptides and the opiate receptor, in: Frontiers in Neuroendocrinology, Vol. 5 (W.F. Ganong and L. Martini, eds.), pp. 289–378, Raven Press, New York, 1978.Google Scholar
  17. 17.
    I. Bachelot, A.R. Wolfsen, and W.D. Odell, Pituitary and plasma lipotropins: Demonstration of the artifactual nature of β-MSH, J. Clin. Endocrinol. Metab. 44:939, 1977.PubMedCrossRefGoogle Scholar
  18. 18.
    L.S. Rees, Human adrenocorticotropin and lipotropin (MSH) in health and disease, in: Clinical Neuroendocrinology (L. Martini and G.M. Besser, eds.), pp. 401–441, Academic Press, New York, 1977.Google Scholar
  19. 19.
    R. Guillemin, T. Vargo, J. Rossier, S. Minick, N. Ling, C. Rivier, W. Vale, and F. Bloom, β-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland, Science 197:1367, 1977.PubMedCrossRefGoogle Scholar
  20. 20.
    G. Pelletier, R. LeClerc, F. Labrie, J. Cote, M. Chretien, and M. Lis, Immunohistochemical localization of β-lipotropic hormone in the pituitary gland, Endocrinology 100:770, 1977.PubMedCrossRefGoogle Scholar
  21. 21.
    R.E. Mains, B.A. Eipper, and N. Ling, Common precursor to corticotropins and endorphins, Proc. Natl. Acad. Sci. U.SA. 74:3014, 1977.CrossRefGoogle Scholar
  22. 22.
    J.L. Roberts and E. Herbert, Characterization of a common precursor to corticotropin and β-lipotropin: Identification of β-lipotropin peptides and their arrangement relative to corticotropin in the precursor synthesized in a cell-free system, Proc. Natl. Acad. Sci. U.SA. 74:5300, 1977.CrossRefGoogle Scholar
  23. 23.
    M. Rubinstein, S. Stein, and S. Udenfriend, Characterization of pro-opiocortin, a precursor to opioid peptides and corticotropin, Proc. Natl. Acad. Sci. U.S.A. 75:669, 1978.PubMedCrossRefGoogle Scholar
  24. 24.
    L.J. Deftos, D. Burton, B.D. Catherwood, H.B. Bone, J.G. Parthemore, R. Guillemin, W.B. Watkins, and R.Y. Moore, Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary, J. Clin. Endocrinol. Metab. 47:457, 1978.PubMedCrossRefGoogle Scholar
  25. 25.
    G.M. Besser and C.R.W. Edwards, Cushing’s syndrome, Clin. Endocrinol. Metab. 1:451, 1972.CrossRefGoogle Scholar
  26. 26.
    C.M. Plotz, A.I. Knowlton, and C. Ragan, The natural history of Cushing’s syndrome, Am. J. Med. 13:597, 1952.PubMedCrossRefGoogle Scholar
  27. 27.
    G.W. Liddle, The adrenal cortex in: Textbook of Endocrinology (R.H. Williams, ed.), pp. 233–283, W.B. Saunders, Philadelphia, 1974.Google Scholar
  28. 28.
    L. Krakoff, G. Nicolis, and B. Amsel, Pathogenesis of hypertension in Cushing’s syndrome, Am. J. Med. 58:216, 1975.PubMedCrossRefGoogle Scholar
  29. 29.
    T.G. Dalakos, A.N. Elias, G.H. Anderson Jr., D.H.P. Streeten, and E.T. Schroeder, Evidence for an angiotensinogenic mechanism of the hypertension of Cushing’s syndrome, J. Clin. Endocrinol. Metab. 46:114, 1978.PubMedCrossRefGoogle Scholar
  30. 30.
    Q.R. Regestein, L.I. Rose, and G.H. Williams, Psychopathology in Cushing’s syndrome, Arch. Intern. Med. 130:114, 1972.PubMedCrossRefGoogle Scholar
  31. 31.
    C.K. Smith, J. Barish, J. Correa, and R.H. Williams, Psychiatric disturbance in endocrine disease, Psychosom. Med. 34:69, 1972.PubMedGoogle Scholar
  32. 32.
    P.A. Lee, V.V. Weldon, and C.J. Migeon, Short stature as the only clinical sign of Cushing’s syndrome, J. Pediatr. 86:89, 1975.PubMedCrossRefGoogle Scholar
  33. 33.
    I.L. Solomon and E.J. Schoen, Juvenile Cushing syndrome manifested primarily by growth failure, Am. J. Dis. Child. 130:200, 1976.PubMedGoogle Scholar
  34. 34.
    R.G. McArthur, M.D. Cloutier, A.B. Hayles, and R.G. Sprague, Cushing’s disease in children: Findings in 13 cases, Mayo Clin. Proc. 47:318, 1972.PubMedGoogle Scholar
  35. 35.
    D.H.P. Streeten, F.H. Faas, M.J. Elders, T.G. Dalakos, and M. Voorhess, Hypercortisolism in childhood: Shortcomings of conventional diagnostic criteria, Pediatrics 56:797, 1975.PubMedGoogle Scholar
  36. 36.
    K. Kreines and W.D. DeVanx, Neonatal adrenal insufficiency associated with maternal Cush-ing’s syndrome, Pediatrics 47:516, 1971.PubMedGoogle Scholar
  37. 37.
    A.M. Hutter, and D.E. Kayhoe, Adrenal cortical carcinoma: Clinical features of 138 patients, Am. J. Med 41:580, 1966.Google Scholar
  38. 38.
    W.K. Stewart, L.W. Fleming, and H.H. Wotiz, The feminizing syndrome in male subjects with adrenocortical neoplasms, Am. J. Med. 37:455, 1964.PubMedCrossRefGoogle Scholar
  39. 39.
    G.W. Liddle, W.E. Nicholson, D.P. Island, D.N. Orth, K. Abe, and S.C. Lowder, Clinical and laboratory studies of ectopic humoral syndromes, Recent Prog. Horm. Res. 25:283, 1969.Google Scholar
  40. 40.
    W.D. Odell and A.R. Wolfsen, Humoral syndromes associated with cancer, Annu. Rev. Med. 29:379, 1978.PubMedCrossRefGoogle Scholar
  41. 41.
    E.M. Rosenberg, T.J. Hahn, D.N. Orth, L.J. Deftos, and K. Tanaka, ACTH-secreting medullary carcinoma of the thyroid presenting as severe idiopathic osteoporosis and senile purpura: Report of a case and review of the literature, J. Clin. Endocrinol. Metab. 47:255, 1978.PubMedCrossRefGoogle Scholar
  42. 42.
    G. Gewirtz and R.S. Yalow, Ectopic ACTH production in carcinoma of the lung, J. Ciin. Invest. 53:1022, 1974.CrossRefGoogle Scholar
  43. 43.
    W.D. Odell, A. Wolfsen, Y. Yoshimoto, R. Weitzman, and D. Fisher, Ectopic peptide synthesis: A universal concomitant of neoplasia, Clin. Res. 25:149A, 1977.Google Scholar
  44. 44.
    A. Wolfsen and W. Odell, Big-ACTH and β-lipotropin: Production by colon and lung cancer, Clin. Res. 25:107A, 1977.Google Scholar
  45. 45.
    G.V. Upton and T.T. Amatruda Jr., Evidence for the presence of tumor peptides with cortico-tropin-releasing factor-like activity in the ectopic ACTH syndrome, N. Engl. J. Med. 285:419, 1971.PubMedCrossRefGoogle Scholar
  46. 46.
    T. Suda, H. Demura, R. Demura, I. Wakabayashi, K. Nomura, E. Odagiri, and K. Shizume, Corticotropin-releasing factor-like activity in ACTH producing tumors, J. Clin. Endocrinol. Metab. 44:440, 1977.PubMedCrossRefGoogle Scholar
  47. 47.
    R.L. Eddy, A.L. Jones, P.F. Gilliland, J.D. Ibarra Jr., J.Q. Thompson, and J.F. McMurry Jr., Cushing’s syndrome: A prospective study of diagnostic methods, Am. J. Med. 55:621, 1973.PubMedCrossRefGoogle Scholar
  48. 48.
    C.A. Nugent, T. Nichols, and F.H. Tyler, Diagnosis of Cushing’s syndrome: Single dose suppression test, Arch. Intern. Med. 116:172, 1965.PubMedCrossRefGoogle Scholar
  49. 49.
    C.T. Sawin, G.A. Bray, and B.A. Idelson, Overnight suppression test with dexamethasone in Cushing’s syndrome, J. Clin. Endocrinol. Metab. 28:422, 1968.PubMedCrossRefGoogle Scholar
  50. 50.
    G.W. Liddle, Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome, J. Clin. Endocrinol. Metab. 12:1539, 1960.CrossRefGoogle Scholar
  51. 51.
    T. Nichols, C.A. Nugent, and F.H. Tyler, Steroid laboratory tests in the dignosis of Cushing’s syndrome, Am. J. Med. 45:116, 1968.CrossRefGoogle Scholar
  52. 52.
    T. Suda, A. Liotta, and D.T. Krieger, Plasma lipotropin (LPH) and ACTH secretion in normal subjects and patients with pituitary-adrenal disease, Program of the 60th Annual Meeting of the Endocrine Society, p. 224, 1978.Google Scholar
  53. 53.
    E. Wiedemann, T. Saito, and J.A. Linfoot, Elevated plasma β-lipotropin in Cushing’s disease due to pituitary adenoma, Program of the 60th Annual Meeting of the Endocrine Society, p. 227, 1978.Google Scholar
  54. 54.
    J.J.H. Gilkes, L.H. Rees, and G.M. Besser, Plasma immunoreactive corticotrophin and lipo-trophin in Cushing’s syndrome and Addison’s disease, Br. Med. J. 1:996, 1977.PubMedCrossRefGoogle Scholar
  55. 55.
    J.H. Pratt, C.T. Sawin, and J.C Melby, Remission of Cushing’s disease after administration of adrenocorticotropin, Am. J. Med. 57:949, 1974.PubMedCrossRefGoogle Scholar
  56. 56.
    J.F. Redman and F.H. Faas, Acute unilateral adrenal hemorrhage following ACTH administration in a patient with Cushing’s syndrome, Am. J. Med. 61:533, 1976.PubMedCrossRefGoogle Scholar
  57. 57.
    G.L. Treece, D.J. Magelssen, and B.L. Fariss, Conjugated estrogens and the overnight dexamethasone suppression test, Obstet Gynecol. 50:407, 1977.PubMedGoogle Scholar
  58. 58.
    E.E. Werk Jr., Y. Choi, L. Sholiton, C. Olinger, and N. Hague, Interference in the effect of dexamethasone by diphenylhydantoin, N. Engl. J. Med. 281:32, 1969.PubMedCrossRefGoogle Scholar
  59. 59.
    N. Hague, K. Thrasher, E.E. Werk Jr., H.C Knowles Jr., and L.J. Sholiton, Studies on dexamethasone metabolism in man; effect of diphenylhydantoin, J. Clin. Endocrinol. Metab. 34:44, 1972.CrossRefGoogle Scholar
  60. 60.
    D.H.P. Streeten, C.T. Stevenson, T.G. Dalakos, J.J. Nicholas, L.G. Dennick, and H. Fellerman, The diagnosis of hypercortisolism: Biochemical criteria differentiating patient from lean and obese normal subjects and from females on oral contraceptives, J. Clin. Endocrinol. Metab. 29:1191, 1969.PubMedCrossRefGoogle Scholar
  61. 61.
    E.J. Sachar, L. Hellman, H.P. Roffwarg, F.S. Halpern, T.K. Fukushima, and T.F. Gallagher, Disrupted 24 hour patterns of Cortisol secretion in psychotic depression, Arch. Gen. Psychiatry 28:19, 1973.PubMedCrossRefGoogle Scholar
  62. 62.
    P.G. Ettigi and G.M. Brown, Psychoneuroendocrinology of affective disorder; an overview, Am. J. Psychiatry 134:493, 1977.PubMedGoogle Scholar
  63. 63.
    R. Demura, H. Demura, T. Nunokawa, H. Baba, and K. Miura, Responses of plasma ACTH, GH, LH and 11-hydroxycorticosteroids to various stimuli in patients with Cushing’s syndrome, J. Clin. Endocrinol. Metab. 34:852, 1972.PubMedCrossRefGoogle Scholar
  64. 64.
    L.H. Rees, G.M. Besser, W.J. Jeffcoate, D.J. Goldie, and V. Marks, Alcohol induced pseudo-Cushing’s syndrome, Lancet 1:726, 1977.PubMedCrossRefGoogle Scholar
  65. 65.
    E.J. Rayfield, L.I. Rose, J.P. Cain, R.G. Dluhy, and G.H. Williams, ACTH-responsive, dex-amethasone-suppressible adrenocortical carcinoma, N. Engl. J. Med. 284:591, 1971.PubMedCrossRefGoogle Scholar
  66. 66.
    A.M.S. Mason, J.G. Ratcliffe, R.M. Buckle, and A.S. Mason, ACTH secretion by bronchial carcinoid tumours, Clin. Endocrinol. 1:3, 1972.CrossRefGoogle Scholar
  67. 67.
    G.W. Liddle, Cushing’s syndrome, Ann. N.Y. Acad. Sci. 297:594, 1977.PubMedCrossRefGoogle Scholar
  68. 68.
    D.T. Krieger and S.M. Glick, Growth hormone and Cortisol responsiveness in Cushing’s syndrome, Am. J. Med. 52:25, 1972.PubMedCrossRefGoogle Scholar
  69. 69.
    D.T. Krieger, P.J. Howanitz, and A.G. Frantz, Absence of nocturnal elevation of plasma prolactin concentrations in Cushing’s disease, J. Clin. Endocrinol. Metab. 42:260, 1976.PubMedCrossRefGoogle Scholar
  70. 70.
    L.G. Lagerquist, A.W. Meikle, C.D. West, and F.H. Tyler, Cushing’s disease with cure by resection of a pituitary adenoma: Evidence against a primary hypothalamic defect, Am. J. Med. 57:826, 1974.PubMedCrossRefGoogle Scholar
  71. 71.
    J.B. Tyrrell, J. Wiener-Kronish, M. Lorenzi, R.M. Brooks, and P.H. Forsham, Cushing’s disease; growth hormone response to hypoglycemia after correction of hypercortisolism, J. Clin. Endocrinol. Metab. 44:218, 1977.PubMedCrossRefGoogle Scholar
  72. 72.
    S.T. Bigos, F. Robert, G. Pelletier, and J. Hardy, Cure of Cushing’s disease by transsphenoidal removal of a microadenoma from a pituitary gland despite a radiographically normal sella turcica, J. Clin. Endocrinol. Metab. 45:1251, 1977.PubMedCrossRefGoogle Scholar
  73. 73.
    A.M. Schnall, J.S. Brodkey, B. Kaufman, and O.H. Pearson, Pituitary function after removal of pituitary microadenomas in Cushing’s disease, J. Clin. Endocrinol. Metab. 47:410, 1978.PubMedCrossRefGoogle Scholar
  74. 74.
    R.M. Salassa, T.P. Kearns, J.W. Kernohan, R.G. Sprague, and C.S. MacCarty, Pituitary tumors in patients with Cushing’s syndrome, J. Clin. Endocrinol. Metab. 19:1523, 1959.PubMedCrossRefGoogle Scholar
  75. 75.
    R.M. Salassa, E.R. Laws Jr., P.C. Carpenter, and R.C Northcutt, Transsphenoidal removal of pituitary microadenoma in Cushing’s disease, Mayo Clin. Proc. 53:24, 1978.PubMedGoogle Scholar
  76. 76.
    J.B. Tyrrell, R.M. Brooks, P.A. Fitzgerald, P.B. Cofoid, P.H. Forsham, and C.B. Wilson, Cushing’s disease; selective transsphenoidal resection of pituitary microadenomas, N. Engl. J. Med. 298:753, 1978.PubMedCrossRefGoogle Scholar
  77. 77.
    A.M. Lawrence, I.D. Goldfine, and L. Kirsteins, Growth hormone dynamics in acromegaly, J. Clin. Endocrinol. Metab. 31:239, 1970.PubMedCrossRefGoogle Scholar
  78. 78.
    D.N. Orth and G.W. Liddle, Results of treatment in 108 patients with Cushing’s syndrome, N. Engl. J. Med. 285:243, 1971.PubMedCrossRefGoogle Scholar
  79. 79.
    J. Hardy and J.L. Vezina, Transsphenoidal neurosurgery of intracranial neoplasm, Adv. Neurol. 15:261, 1976.PubMedGoogle Scholar
  80. 80.
    R.B. Welbourn, D.A.D. Montgomery, and T.L. Kennedy, The natural history of treated Cushing’s syndrome, Br. J. Surg. 58:1, 1971.PubMedCrossRefGoogle Scholar
  81. 81.
    L. des Quieroz, N.O. Facure, J.J. Facure, N.P. Modesto, and J.L. deFaria, Pituitary carcinoma with liver metastases and Cushing syndrome, Arch. Pathol. 99:32, 1975.Google Scholar
  82. 82.
    M.W. Edmonds, W.J.K. Simpson, and J.W. Meakin, External irradiation of the hypophysis for Cushing’s disease, Can. Med. Assoc. J. 107:860, 1972.PubMedGoogle Scholar
  83. 83.
    R. Heuschele and I. Lampe, Pituitary irradiation for Cushing’s syndrome, Radiol. Clin. Biol. 36:27, 1967.PubMedGoogle Scholar
  84. 84.
    A.S. Jennings, G.W. Liddle, and D.N. Orth, Results of treating childhood Cushing’s disease with pituitary irradiation, N. Engl. J. Med. 297:957, 1977.PubMedCrossRefGoogle Scholar
  85. 85.
    C.W. Burke, F.H. Doyle, G.F. Joplin, R.N. Arnot, D.P. Macerlean, and T.R. Fraser, Cushing’s disease: Treatment by pituitary implantation of radioactive gold or yttrium seeds, Q. J. Med. 42:693, 1973.PubMedGoogle Scholar
  86. 86.
    R. Fletcher, G.A. Dalton, M.H.B. Carmalt, and W.T. Smith, The treatment of Cushing’s syndrome by trans ethmoidal hypophysectomy, Acta. Endocrinal. 67:(Suppl. 155):163, 1971.Google Scholar
  87. 87.
    D.E. Schteingart, J.W. Conn, L.M. Lieberman, and W.H. Beierwaltes, Persistent or recurrent Cushing’s syndrome after “total” adrenalectomy, Arch. Intern. Med. 130:384, 1972.PubMedCrossRefGoogle Scholar
  88. 88.
    G.O. Strauch and L. Vinnick, Persistent Cushing’s syndrome apparently cured by ectopic adrenalectomy, J. Am. Med. Assoc. 222:183, 1972.CrossRefGoogle Scholar
  89. 89.
    P.D. Papapetrou and I. Jackson, Cortisol secretion in Nelson syndrome: Persistence after “total” adrenalectomy for Cushing syndrome, J. Am. Med. Assoc. 234:847, 1974.CrossRefGoogle Scholar
  90. 90.
    H.W. Scott Jr., G.W. Liddle, J.L. Mulherin Jr., T.J. McKenna, S.L. Stroup, and R.K. Rhamy, Surgical experience with Cushing’s disease, Ann. Surg. 185:524, 1977.PubMedCrossRefGoogle Scholar
  91. 91.
    D.H. Nelson, J.W. Meakin, J.B. Dealy Jr., D.D. Matson, K. Emerson Jr., and G.W. Thron, ACTH producing tumor of the pituitary gland, N. Engl. J. Med. 259:161, 1958.PubMedCrossRefGoogle Scholar
  92. 92.
    T.J. Moore, R.G. Dluhy, G.H. Williams, and J.P. Cain, Nelson’s syndrome; frequency, prognosis, and effect of prior pituitary irradiation, Ann. Intern. Med. 85:731, 1976.PubMedGoogle Scholar
  93. 93.
    K.L. Cohen, R.H. Noth, and T. Pechinski, Incidence of pituitary tumors following adrenalectomy. A long term follow-up study of patients treated for Cushing’s disease, Arch. Intern. Med. 138:575, 1978.PubMedCrossRefGoogle Scholar
  94. 94.
    N.J. Hopwood and F.M. Kenny, Incidence of Nelson’s syndrome after adrenalectomy for Cushing’s disease in children, Am. J. Dis. Child. 131:1353, 1977.PubMedGoogle Scholar
  95. 95.
    M.E. Molitch, Endocrinology, in: Management of Medical Problems in Surgical Patients (M.E. Molitch, ed.), F.A. Davis, Philadelphia, 1980 (in press).Google Scholar
  96. 96.
    A.L. Graber, R.L. Ney, W.E. Nicholson, D.P. Island, and G.W. Liddle, Natural history of pituitary-adrenal recovery following long term suppression with corticosteroids, J. CJin. Endocrinol. Metab. 25:11, 1965.CrossRefGoogle Scholar
  97. 97.
    R.L. Byyny, Withdrawal from glucocorticoid therapy, N. Engl. J. Med. 295:30, 1976.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1980

Authors and Affiliations

  • Mark E. Molitch
    • 1
  1. 1.Department of Medicine, Division of Endocrinology, Tufts-New England Medical Center HospitalTufts University School of MedicineBostonUSA

Personalised recommendations